Anxiety disorders prevention: Overview and focus on post-traumatic stress disorder

Minerva Psichiatrica

Volumn 50, Issue 3, 2009, Pages 265-275

  Bienvenu, O J ^a   Gould, N F ^a   Mason, S T ^a   Fauerbach, J A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety disorders; Mental disorders; Stress disorders, post traumatic

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CLONAZEPAM; CORTICOSTEROID; FLUOXETINE; GABAPENTIN; HYDROCORTISONE; IMIPRAMINE; MORPHINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM;

ACUTE STRESS DISORDER; AGE DISTRIBUTION; AGORAPHOBIA; ANTIINFLAMMATORY ACTIVITY; ANXIETY DISORDER; AROUSAL; BEHAVIOR; CHILD PARENT RELATION; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONVALESCENCE; CRITICAL ILLNESS; DEPRESSION; DRUG DOSE REDUCTION; EVENING DOSAGE; EXTRAVERSION; FAMILY HISTORY; GENERALIZED ANXIETY DISORDER; HEART SURGERY; HIGH RISK POPULATION; HUMAN; INJURY; INTENSIVE CARE; JUVENILE; KNOWLEDGE; LOW DRUG DOSE; MEDICAL EDUCATION; MOOD DISORDER; NEUROSIS; OBSESSIVE COMPULSIVE DISORDER; PAIN; PANIC; PATIENT EDUCATION; PERSONALITY; POSTTRAUMATIC STRESS DISORDER; PUBLIC HEALTH; REVIEW; RISK; RISK FACTOR; SEPTIC SHOCK; SEX RATIO; SOCIOECONOMICS; SUBSTANCE ABUSE; TEMPERAMENT; TREATMENT RESPONSE;

EID: 76049111101     PISSN: 03911772     EISSN: 18271731     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Bienvenu OJ, Ginsburg GS. Prevention of anxiety disorders. Int Rev Psychiatry 2007;19:647-54.
2. Bienvenu OJ, Siegel DJ, Ginsburg GS. Prevention of anxiety disorders. In: Compton MT, editor. Clinical manual of prevention principles in mental health care. Washington, DC: American Psychiatric Publishing, Inc.; [In press].
3. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry 2001;178:145-53.
4. Costello EJ, Egger H, Angold A. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am 2005;14:631-48.
5. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004;291:2581-90.
6. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005;15:357-76.
7. Kessler RC, Berglund P, Demier O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
8. Kessler RC, Chiu WT, Merikangas KR, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27.
9. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JRT et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999;60:427-35.
10. Lepine JP. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry 2002;63:4-8.
11. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A. Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006;9:193-200.
12. Murray CL, Lopez AD. The global burden of disease. Cambridge, MA: Harvard University Press; 1996.
13. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry 1999;56:921-6.
14. Goodwin RD, Gorman JM. Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. Am J Psychiatry 2004;159:1935-7.
15. Wittchen HU, Beesdo K, Bittner A, Goodwin RD. Depressive episodes evidence for a causal role of primary anxiety disorders? Eur Psychiatry 2003;18:384-93.
16. Chavira DA, Stein MB, Bailey K, Stein MT. Child anxiety in primary care: prevalent but untreated. Depress Anxiety 2004;20:155-64.
17. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States. Arch Gen Psychiatry 2005;62:629-40.
18. Bekker MH, van Mens-Verhulst J. Anxiety disorders: sex differences in prevalence, degree, and background, but gender-neutral treatment. Gend Med 2007;4(Suppl B):S178-93.
19. Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry [Epub ahead of print].
20. Merikangas KR. Vulnerability factors for anxiety disorders in children and adolescents. Child Adolesc Psychiatr Clin N Am 2005;14:649-79.
21. Craske MG, Barlow DH, Clark DM, Curtis GC, Hill EM, Himle JA et al. Specific (simple) phobias. In: Widiger TA, Frances, AJ, Pincus HA, Ross R, First MB, Davis WW, editors. DSM-IV Sourcebook. Washington, DC: American Psychiatric Association; 1996. p. 473-506.
22. Kessler RC, Keller MB, Wittchen HU. The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am 2001;24:19-39.
23. Moffitt TE, Caspi A, Harrington H, Milne BJ, Melchior M, Goldberg D et al. Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32. Psychol Med 2007;37:441-52.
24. Phillips NK, Hammen CL, Brennan PA, Najman JM, Bor W. Early adversity and the prospective prediction of depressive and anxiety disorders in adolescents. J Abnorm Child Psychol 2005;33:13-24.
25. Wittchen HU, Kessler RC, Pfister H, Lieb. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand 2000;102 (Suppl 406):14-23.
26. Beidel DC, Turner SM. At risk for anxiety: I. Psychopathology in the offspring of anxious parents. J Am Acad Child Adolesc Psychiatry 1997;36:918-24.
27. Hettema JM. What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 2008;148:140-6.
28. Hirshfeld-Becker DR, Micco JA, Simoes NA, Henin A. High risk studies and developmental antecedents of anxiety disorders. Am J Med Genet C Semin Med Genet 2008;148:99-117.
29. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-78.
30. Bienvenu OJ, Stein MB. Personality and anxiety disorders: a review. J Personal Disord 2003;17: 139-51.
31. Brandes M, Bienvenu OJ. Personality and anxiety disorders. Curr Psychiatry Rep 2006;8:263-9.
32. Bienvenu OJ, Hettema JM, Neale MC, Prescott CA, Kendler KS. Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. Am J Psychiatry 2007;164:1714-21.
33. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 2006;163:857-64.
34. McLeod BD, Wood JJ, Weisz JR. Examining the association between parenting and childhood anxiety: a meta-analysis. Clin Psychol Rev 2007;27:155-72.
35. Ginsburg GS, Grover R, Ialongo N. Parenting behaviors among anxious and non-anxious mothers: relation with concurrent and long-term child outcomes. Child Fam Behav Ther 2004;26:23-41.
36. Mrazek PJ, Haggerty RJ. Reducing risks for mental disorders: frontiers for preventive intervention research. Washington, DC: National Academy Press; 1994.
37. Barrett PM, Turner C. Prevention of anxiety symptoms in primary school children: preliminary results from a universal school-based trial. Br J Clin Psychol 2001;40:399-410.
38. Barrett P, Sonderegger R, Xenos S. Using FRIENDS to combat anxiety and adjustment problems among young migrants to Australia: A national trial. Clin Child Psychol Psychiatry 2003;8:241-60.
39. Barrett PM, Farrell LJ, Ollendick TH, Dadds M. Long-term outcomes of an Australian universal prevention trial of anxiety and depression symptoms in children and youth: an evaluation of the FRIENDS program. J Clin Child Adolesc Psychol 2006;35:403-11.
40. Lock S, Barrett P. A longitudinal study of developmental differences in universal preventive intervention for child anxiety. Behav Change 2003;10:183-99.
41. Lowry-Webster H, Barrett PM, Dadds M. A universal prevention trial of anxiety and depressive symptomatology in childhood: preliminary data from an Australian study. Behav Change 2003;20:25-43.
42. Rapee RM. The development and modification of temperamental risk for anxiety disorders: prevention of a lifetime of anxiety? Biol Psychiatry 2002;52:947-57.
43. Rapee RM, Kennedy S, Ingram M, Edwards S, Sweeney L. Prevention and early intervention of anxiety disorders in inhibited preschool children. J Consult Clin Psychol 2005;73:488-97.
44. Ginsburg GS. Anxiety prevention programs for youth: practical and theoretical considerations. Clin Psychol (New York) 2004;11:430-4.
45. Seligman MEP, Schulman P, DeRubeis RJ, Hollon SD. The prevention of depression and anxiety. Prevention and Treatment 1999;2.
46. Seligman ME, Schulman P, Tyron AM. Group prevention of depression and anxiety symptoms. Behav Res Ther 2007;45:1111-26.
47. Dadds MR, Spence SH, Holland DE, Barrett PM, Laurens KR. Prevention and early intervention for anxiety disorders: a controlled trial. J Consult Clin Psychol 1997;65:627-35.
48. Kendall PC. Treatment of anxiety disorders in children: a randomized controlled trial. J Consul Clin Psychol 1994;62:100-10.
49. Dadds MR, Holland DE, Laurens KR, Mullins M, Barrett PM, Spence SH. Early intervention and prevention of anxiety disorders in children: results at 2-year follow-up. J Consult Clin Psychol 1999;67:145-50.
50. Donovan CL, Spence SH. Prevention of childhood anxiety disorders. Clin Psychol Rev 2000;20:509-31.
51. Kellam SG, Van Horn YV. Life course development, community epidemiology, and preventive trials: a scientific structure for prevention research. Am J Community Psychol 1997;25:177-88.
52. Bienvenu OJ, Stein MB, Samuels JF, Onyike CU, Eaton WW, Nestadt G. Personality disorder traits as predictors of subsequent first-onset panic disorder or agoraphobia. Compr Psychiatry 2009;50:209-14.
53. Insel T, Fenton W. Psychiatric epidemiology: it's not just about counting anymore. Arch Gen Psychiatry 2005;62:590-2.
54. Kessler RC, Zhao S, Katz SJ, Kouzis AC, Frank RG, Edlund M et al. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry 1999;156:115-23.
55. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:603-13.
56. Wang PS, Dernier O, Olfson M, Pincus HA, Wells KB, Kessler RC. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry 2006;163:1187-98.
57. Rosen GM, Spitzer RL, McHugh PR. Problems with the post-traumatic stress disorder diagnosis and its future in DSM-V. Br J Psychiatry 2008;192:3-4.
58. Rose S, Bisson J, Churchill R, Wessely S. Psychological debriefing for preventing post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2002;issue 2.
59. van Emmerik AA, Kamphuis JH, Hulsbosch AM, Emmelkamp PM. Single session debriefing after psychological trauma: a meta-analysis. Lancet 2002;360:766-71.
60. Roberts NP, Kithiner NJ, Kenardy J, Bisson JI. Systematic review and meta-analysis of multiple-session interventions following traumatic events. Am J Psychiatry 2009 [Epublished ahead of print].
61. Foa EB, Keane TM, Friedman MJ. Effective treatments for PTSD: practice guidelines from the international society for traumatic stress studies. New York, NY: Guilford Press; 2000.
62. Bryant RA, Harvey AG, Sackville T, Dang S, Basten C. Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol 1998;66:862-6.
63. Bryant RA, Sackville T, Dang ST, Moulds M, Guthrie R. Treating acute stress disorder: an evaluation of cognitive behavior therapy and counseling techniques. Am J Psychiatry 1999;156:1780-6.
64. Bryant RA, Moulds M, Guthrie RM, Nixon RD. The additive benefit of hypnosis and cognitive behavior therapy in treating acute stress disorder. J Consult Clin Psychol 2005;73:334-40.
65. Bryant RA, Moulds ML, Nixon RV, Mastrodomenico J, Felmingham K, Hopwood S. Hypnotherapy and cognitive behaviour therapy of acute stress disorder: a three-year follow-up. Behav Res Ther 2006;44:1331-5.
66. Bryant RA, Mastrodomenico J, Felmingham KL, Hopwood S, Kenny L, Kandris E et al. Treatment of acute stress disorder: a randomized controlled trial. Arch Gen Psychiatry 2008;65:659-67.
67. Foa EB, Zoellner LA, Feeny NC. An evaluation of three brief programs for facilitating recovery after assault. J Trauma Stress 2006;19:29-43.
68. Sijbrandij M, Olff M, Reitsma JB, Carlier IV, de Vries MH, Gersons BP. Treatment of acute posttraumatic stress disorder with brief cognitive behavioral therapy: a randomized controlled trial. Am J Psychiatry 2007;164:82-90.
69. Shalev AY, Segman RH. Commentary: biological findings in PTSD - too much or too little? Prog Brain Res 2008;167:187-99.
70. Pitman RK. Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 1989;26:221-3.
71. Yehuda R, McFarlane AC, Shalev AY. Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 1998;44:1305-13.
72. Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR et al. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:169-80.
73. Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B et al. Practice guideline for the treatment of patients with acute stress disorder and post-traumatic stress disorder. Am J Psychiatry 2004;161:3-31.
74. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-4.
75. Mellman TA, Bustamante V, David D, Fins AI. Hypnotic medication in the aftermath of trauma. J Clin Psychiatry 2002;63:1183-4.
76. Davydow DS, Desai SV, Needham DM, Bienvenu OJ. Psychiatric morbidity in survivors of the acute respiratory distress syndrome: a systematic review. Psychosom Med 2008;70:512-9.
77. Davydow DS, Gifford JM, Desai SV, Needham DM, Bienvenu OJ. Posttraumatic stress disorder following intensive care: a systematic review. Gen Hosp Psychiatry 2008;30:421-34.
78. Saxe G, Stoddard F, Courtney D, Cunningham K, Chawla N, Sheridan R et al. Relationship between acute morphine and the course of PTSD in children with burns. J Am Acad Child Adolesc Psychiatry 2001;40:915-21.
79. Bryant RA, Creamer M, O'Donnell M, Silove D, McFarlane AC. A study of the protective function of acute morphine administration on subsequent post-traumatic stress disorder. Biol Psychiatry 2009;65:438-40.
80. Davidson JRT. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry 2006;67(Suppl 2):34-9.
81. rd. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 1999;38:873-82.
82. Robert R, Tcheung WJ, Rosenberg L, Rosenberg M, Mitchell C, Villarreal C et al. Treating thermally injured children suffering symptoms of acute stress with Imipramine and fluoxetine: a randomized, double-blind study. Burns 2008:34:919-28.
83. Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 2002;51:189-92.
84. Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 2003;54:947-9.
85. Stein MB, Kerridge C, Dimsdale JE, Hoyt DB. Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. J Trauma Stress. 2007;20:923-32.
86. Schelling G, Stoll C, Kapfhammer HP, Rothenhäusler HB, Krauseneck T, Durst K et al. The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder and health-related quality of life in survivors. Crit Care Med 1999;27:2678-83.
87. Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhäusler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder in survivors. Biol Psychiatry 2001;50:978-85.
88. Schelling G, Kilger E, Roozendaal B, de Quervain DJ, Briegel J, Dagge A et al. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol Psychiatry 2004;55:627-33.
89. Weis F, Kilger E, Roozendaal B, de Quervain DJ, Lamm P, Schmidt M et al. Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study. J Thorac Cardiovasc Surg 2006;131:277-82.
90. Boer KR, van Ruler O, van Emmeril AAP, Sprangers MA, de Rooij SE, Vroom MB et al. Factors associated with posttraumatic stress symptoms in a prospective cohort of patients after abdominal sepsis: a nomogram. Intensive Care Med 2008;34:664-74.
91. Schelling G, Roozendaal B, Krauseneck T, Schmoelz M, DE Quervain D, Briegel J. Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery. Ann N Y Acad Sci 2006;1071:46-53.
92. Siami S, Annane D, Sharshar T. The encephalopathy in sepsis. Crit Care Clin 2008;24:67-82.
93. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000;68:748-66.
94. Ozer EJ, Best SR, Lipsey TL, Weiss DS. Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull 2003;129:52-73.
95. Kilpatrick DG, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Resnick HS et al. The serotonin transporter genotype and social support and moderation of post-traumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 2007;164:1693-9.
96. Lee HJ, Lee MS, Kang RH, Kim H, Kim SD, Kee BS et al. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 2005;21:135-9.
97. Bramsen I, Dirkzwager AJ, van der Ploeg HM. Predeployment personality traits and exposure to trauma as predictors of posttraumatic stress symptoms: a prospective study of former peacekeepers. Am J Psychiatry 2000;157:1115-9.
98. Breslau N, Davis GC, Andreski P, Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 1991;48:216-22.
99. Fauerbach JA, Lawrence JW, Schmidt CW, Munster AM, Costa PT. Personality predictors of injury-related posttraumatic stress disorder. J Nerv Ment Dis 2000;188:510-7.
100. McFarlane AC. The aetiology of post-traumatic stress disorders following a natural disaster. Br J Psychiatry 1988;152:116-21.
101. Andrews B, Brewin CR, Rose S. Gender, social support, and PTSD in victims of violent crime. J Trauma Stress 2003;16:421-7.
102. Perry S, Difede J, Musngi G, Frances AJ, Jacobsberg L. Predictors of posttraumatic stress disorder after burn injury. Am J Psychiatry 1992;149:931-5.